Mannkind Corp
- Last sale
- Nov 12, 2026 · -0.60%
- Market cap
- $1.34B
- 321.64M shares
- Filings
- 1,032
Q3 2026+22.2% FY25 yoy
Q3 2026−78.7% FY25 yoy
Q3 2026−46.5% FY25 yoy
Q3 2026derived−58.3% FY25 yoy
Q3 2026−80.0% FY25 yoy
Q3 2026+61.6% FY25 yoy
- $1.34B
- —
- 3.2×
- —
- -5.87%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $348,966,000 | reported | |
| FY 2024 | 2024-12-31 | $285,504,000 | reported | |
| FY 2023 | 2023-12-31 | $198,962,000 | reported | |
| FY 2022 | 2022-12-31 | $99,770,000 | reported | |
| FY 2021 | 2021-12-31 | $75,442,000 | reported | |
| FY 2020 | 2020-12-31 | $65,144,000 | reported | |
| FY 2019 | 2019-12-31 | $63,038,000 | reported | |
| FY 2018 | 2018-12-31 | $27,859,000 | reported | |
| FY 2017 | 2017-12-31 | $11,745,000 | reported | |
| FY 2016 | 2016-12-31 | $174,758,000 | reported | |
| FY 2015 | 2015-12-31 | $0 | reported | |
| FY 2014 | 2014-12-31 | $0 | reported |
Segments
Products
LineFY2025ShareChange
Product Revenue$216.52M62%+21.3%
Royalties$128.12M37%+25.2%
AFREZZA product sales$114.14M33%+38.6%
Collaborations and services$106.71M31%+5.8%
Services$4.33M1.2%−6.2%
Manufacturing Services$1.60M0.5%−77.5%
Product Sales———
Total$348.97M
Pharmaceutical preparations
Mannkind Corp is the 65th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
INVAInnoviva, Inc.$411.3M14.7%65.9%$1.3BARDXArdelyx, Inc.$407.3M22.1%15.1%$781.8MSVASinovac Biotech Ltd$386.0M6.8%51.5%$464.9MPHARPharming Group N.V.$376.1M26.6%0.8%$922.0MARQTArcutis Biotherapeutics, Inc.$376.1M91.3%4.3%$3.3B
MNKDMannkind Corp (this company)$349.0M22.2%1.7%$1.3B
CRMDCorMedix Inc.$311.7M617.0%52.3%$427.6MEOLSEvolus, Inc.$297.2M11.6%17.4%$475.2MIRWDIronwood Pharmaceuticals Inc$296.2M15.7%8.1%$801.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Mannkind Corp · CIK 899460 · Engraved from SEC EDGAR